Literature DB >> 19464999

Cholesterol modulates the exposure and orientation of pulmonary surfactant protein SP-C in model surfactant membranes.

L Gómez-Gil1, J Pérez-Gil, E Goormaghtigh.   

Abstract

Cholesterol is the major neutral lipid in lung surfactant, accounting for up to 8-10% of surfactant mass, while surfactant protein SP-C ( approximately 4.2 kDa) accounts for no more than 1-1.5% of total surfactant weight but plays critical roles in formation and stabilization of pulmonary surfactant films. It has been reported that surfactant protein SP-C interacts with cholesterol in lipid/protein interfacial films and this interaction could have a potential role on modulating surfactant function. In the present study, we have analyzed the effect of cholesterol on the structure, orientation and dynamic properties of SP-C embedded in physiologically relevant model membranes. The presence of cholesterol does not induce substantial changes in the secondary structure of SP-C, as analyzed by Attenuated Reflection Fourier Transformed Infrared spectroscopy (ATR-FTIR). However, the presence of cholesterol modifies the orientation of the transmembrane helix and the dynamic properties of the protein, as demonstrated by hydrogen/deuterium exchange kinetics. The effect of cholesterol on SP-C reconstituted in zwitterionic, entirely fluid, membranes made of POPC (palmitoyloleoylphospatidylcholine) or in anionic membranes with coexistence of ordered and disordered phases, such as those made of dipalmitoylphosphatidylcholine (DPPC):POPC:Palmitoyloleoylphosphatidylglycerol (POPG) (50:25:15) is dual. Cholesterol decreases the exposure of the protein to the aqueous environment and the tilt of its transmembrane helical segment up to a ratio Cholesterol:SP-C of 4.8 and 2.4 (mol/mol) in the two lipid systems tested, respectively, and it increases the exposure and tilt at higher cholesterol proportions. The results presented here suggest the existence of an interaction between SP-C and cholesterol-enriched phases, with consequences on the behavior of the protein, which could be of relevance for cholesterol-dependent structure-function relationships in pulmonary surfactant membranes and films.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464999     DOI: 10.1016/j.bbamem.2009.05.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression/expansion dynamics in cholesterol-containing surfactant films.

Authors:  Florian Baumgart; Olga L Ospina; Ismael Mingarro; Ignacio Rodríguez-Crespo; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

2.  Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.

Authors:  Nuria Roldan; Thomas K M Nyholm; J Peter Slotte; Jesús Pérez-Gil; Begoña García-Álvarez
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

3.  Comparative study of clinical pulmonary surfactants using atomic force microscopy.

Authors:  Hong Zhang; Qihui Fan; Yi E Wang; Charles R Neal; Yi Y Zuo
Journal:  Biochim Biophys Acta       Date:  2011-03-23

4.  Combined effect of synthetic protein, Mini-B, and cholesterol on a model lung surfactant mixture at the air-water interface.

Authors:  Aishik Chakraborty; Erica Hui; Alan J Waring; Prajnaparamita Dhar
Journal:  Biochim Biophys Acta       Date:  2016-01-15

Review 5.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

6.  Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNA.

Authors:  Roberta Guagliardo; Pieterjan Merckx; Agata Zamborlin; Lynn De Backer; Mercedes Echaide; Jesus Pérez-Gil; Stefaan C De Smedt; Koen Raemdonck
Journal:  Pharmaceutics       Date:  2019-08-23       Impact factor: 6.321

Review 7.  Alveolar Dynamics and Beyond - The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis.

Authors:  Kirsten Sehlmeyer; Jannik Ruwisch; Nuria Roldan; Elena Lopez-Rodriguez
Journal:  Front Physiol       Date:  2020-05-05       Impact factor: 4.566

Review 8.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19.

Authors:  Lore Herman; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2021-11-20       Impact factor: 9.776

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.